Founded in 1991 and headquartered in Zhuhai, Guangdong Province, Guangdong VTR Bio-Tech Co., Ltd. (广东溢多利生物科技股份有限公司) is one of China's leading biotechnology enterprises specializing in enzyme preparation, bio-synthesis, plant extracts, and animal nutrition products. The company is listed on the Shenzhen Stock Exchange under the ticker 300381.SZ, highlighting its scale, transparency, and commitment to corporate governance.
Core Business and Product Offerings
VTR Bio-Tech focuses on the research, production, and commercialization of bio-based functional products across multiple sectors, including food, feed, pharmaceuticals, textiles, and pet care. The company's key product segments include:
-
Biological Enzyme Preparations:
- Feed Enzymes: Phytase, xylanase, protease
- Food Enzymes: Baking enzymes, beverage clarifiers
- Textile Enzymes: Biopolishing and desizing agents
-
Biosynthetic Products:
- API intermediates and bio-based fine chemicals
- Active development in green synthesis pathways for pharmaceutical manufacturing
-
Plant Extracts:
- Standardized herbal extracts for dietary supplements
- Functional ingredients for cosmetics and health foods
-
Functional Feed Additives:
- Probiotics, prebiotics, acidifiers, and toxin binders designed for livestock performance enhancement
-
Pet Products:
- Nutritional supplements and functional additives for dogs and cats
These offerings support sustainable and efficient production in agriculture, pharmaceuticals, and food industries.
Specialization and Core USP
VTR Bio-Tech is a pioneer in China’s enzyme biotechnology industry with a focus on green biomanufacturing and sustainable innovation. Its proprietary enzyme production technologies have significantly improved bioavailability and cost-efficiency for feed and food processing industries.
Unique selling propositions include:
- Over 200 domestic and international patents in enzyme and biosynthesis technologies
- Strategic collaborations with Chinese Academy of Sciences, South China Agricultural University, and international R&D institutions
- Leading the application of synthetic biology and precision fermentation in the enzyme and bio-intermediate market
Financial Overview
As a publicly listed company, VTR Bio-Tech has consistently reported strong financial performance:
- Revenue in 2022: CNY 1.95 billion (~USD 270 million)
- Net Profit: CNY 220 million (~USD 30 million)
- R&D Investment: Over CNY 160 million, representing ~8% of annual revenue
- Market Capitalization (as of 2024): Approximately CNY 5.6 billion (~USD 770 million)
These figures reflect the company’s scale, innovation focus, and solid growth trajectory in the biotech sector.
Global Export and Trade Activity
According to international trade data:
- VTR Bio-Tech has active export markets in Asia-Pacific, Europe, and Latin America
- Products such as phytase and protease enzymes are exported to over 40 countries
- The company has obtained multiple registration and compliance approvals for its feed and food enzymes in markets such as Brazil, Thailand, Russia, and the EU
The export segment contributes a growing share of total revenue, supported by regulatory compliance and product quality.
Target Market
VTR Bio-Tech serves a wide variety of B2B clients across:
- Animal nutrition and feed producers
- Food and beverage manufacturers
- Pharmaceutical companies and CDMOs
- Cosmetic and nutraceutical brands
- Pet food and veterinary health product companies
Its enzyme and plant-based solutions are integrated into formulations to enhance product quality, shelf life, digestibility, and bioactivity.
Capabilities
- Five modern manufacturing bases with GMP, ISO22000, and FAMI-QS certifications
- Over 20 fermentation production lines with multi-ton/day capacity
- Central R&D facility and multiple provincial innovation labs
- Customized enzyme engineering and formulation services
- Annual enzyme production exceeding 50,000 metric tons
Certifications and Regulatory Compliance
- ISO9001 and ISO22000 certified
- FAMI-QS and GMP+ for feed additives
- REACH registration in the EU for key enzyme products
- Compliance with China MOA, EFSA, FDA (USA) for respective product categories
VTR Bio-Tech also adheres to green manufacturing practices, focusing on waste minimization and carbon footprint reduction across production cycles.
Major Achievements
- Recognized as National Key High-Tech Enterprise in China
- Selected in “Top 10 Enzyme Enterprises” by China Feed Industry Association
- Part of national 14th Five-Year Plan for biomanufacturing technology innovation
- Exclusive supplier of phytase enzymes for multiple major international feed integrators
Guangdong VTR Bio-Tech Co., Ltd. stands at the forefront of China’s enzyme and synthetic biology industries, offering cutting-edge bio-based solutions with proven global competitiveness. With a strong R&D pipeline, solid financials, and an expanding international footprint, the company continues to lead in green innovation for sustainable industry development.
